Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Revance Therapeutics

Revance Therapeutics reported $18.32M in Stock for its fiscal quarter ending in December of 2022.

Stock Change
Coherus Biosciences CHRS:US USD 114.49M 75.7M
J&J JNJ:US USD 12.81B 326M
Neurocrine Biosciences NBIX:US USD 33.4M 1.7M
P&G PG:US USD 7.48B 58M
Pacira PCRX:US USD 92.98M 3.09M
Supernus Pharmaceuticals SUPN:US USD 91.15M 394K